GRIA1 and glioblastoma: Our work demonstrated that hypomethylator phenotypes in GBM remodel the glutamatergic network, represented by the methylation-dependent induction of GRIA1 (GluR1) which facilitates GBM cell survival and plays a role in predicting the GBM patients’ survival.